HIV vaccine candidate ΔV1gp120 formulated in ALFQA adjuvant augments mucosal immunity in female macaques.

Nat Commun · 2025 · PMC12480912 · PMID 41022728

Europe PMC DOI

hedged sentence

0.1100

closest p · 2.2× alpha

0.1100

boldest claim

The sentences

showed a trendp = 0.11not close (p > 0.1)

Although the study was not powered to compare the two vaccinated groups, the comparison of the viral acquisitions between ALFQA and Alum groups showed a trend towards further delayed viral acquisition ( p = 0.11; Fig. 1d ), but this was not significant.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.